Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery

Journal of Controlled Release

Volumn 57, Issue 1, 1999, Pages 9-18

  Wang, Daqing ^a   Robinson, Deborah R ^a   Kwon, Glen S ^a,b   Samuel, John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Antigen delivery; DNA delivery; Microspheres; Poly(D,L lactic co glycolic acid); Vaccines

Indexed keywords

BETA GALACTOSIDASE; MICROSPHERE; PLASMID DNA; POLYGLACTIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; ENCAPSULATION; GENE STRUCTURE; GENE TARGETING; GENETIC TRANSFECTION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; BETA-GALACTOSIDASE; BIOCOMPATIBLE MATERIALS; CELL LINE; COS CELLS; DEOXYRIBONUCLEASE I; DNA; DRUG COMPOUNDING; GENE TRANSFER TECHNIQUES; LACTIC ACID; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; PHAGOCYTOSIS; PLASMIDS; POLYGLYCOLIC ACID; POLYMERS; TRANSFECTION;

EID: 0032921913     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00099-6     Document Type: Article

References (41)

1. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
2. Hassett D.E., Whitton J.L. DNA immunization. Trends Microbiol. 4(8):1996;307-312.
3. Manickan E., Karem K.L., Rouse B. DNA vaccines - A modern gimmick or a boon to vaccinology. Crit. Rev. Immunol. 17:1997;139-154.
4. Whalen R.G. DNA vaccines for emerging infectious diseases: what if? Emerg. Infect. Dis. 2(3):1996;168-175.
5. Fu T.M., Friedman A., Ulmer J.B., Liu M.A., Donnelly J.J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71(4):1997;2715-2721.
6. Asakura Y., Hamajima K., Fukushima J., Mohri H., Okubo T., Okuda K. Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine. Am. J. Hematol. 53(2):1996;116-117.
7. Conry R.M., LoBuglio A.F., Loechel F., Moore S.E., Sumerel L.A., Barlow D.L., Pike J., Curiel D.T. A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Cancer Gene Ther. 2(1):1995;33-38.
8. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158(10):1997;4529-4532.
9. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2(10):1996;1122-1128.
10. Ruedl C., Wolf H. Features of oral immunization. Int. Arch. Allergy Immunol. 108(4):1995;334-339.
11. McGhee J.R., Xu-Amano J., Miller C.J., Jackson R.J., Fujihashi K., Staats H.F., Kiyono H. The common mucosal immune system: from basic principles to enteric vaccines with relevance for the female reproductive tract. Reprod. Fertil. Dev. 6(3):1994;369-379.
12. Elson C.O. In defense of mucosal surfaces. Regulation and manipulation of the mucosal immune system. Adv. Exp. Med. Biol. 412:1997;373-385.
13. Klavinskis L.S., Gao L., Barnfield C., Lehner T., Parker S. Mucosal immunization with DNA-liposome complexes. Vaccine. 15(8):1997;818-820.
14. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.v., Vijayaraghavan K., Morrell M.S., Morrell B.M., Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386:1997;410-414.
15. Alpar H.O., Ozsoy Y., Bowen J., Eyles J.E., Conway B.R., Williamson E.D. Potential of particulate carriers for the mucosal delivery of DNA vaccines. Biochem. Soc. Trans. 25(2):1997;337S.
16. Eldridge J.H., Staas J.K., Meulbroek J.A., Tice T.R., Gilley R.M. Biodegradable and biocompatible poly(D,L-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 59(9):1991;2978-2986.
17. Alonso M.J., Gupta R.K., Min C., Siber G.R., Langer R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine. 12(4):1994;299-306.
18. Newman K.D., Samuel J., Kwon G. Ovalbumin peptide encapsulated in poly(D,L-lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. J. Contol. Rel. 54(1):1998;49-59.
19. Jones D.H., Corris S., McDonald S., Clegg J.C.S., Farrar G.H. Poly(D,L-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15(8):1997;814-817.
20. Hedley M.L., Curley J., Urban R. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. 4(3):1998;365-368.
21. Ralph P., Nakoinz I. Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture. Cancer Res. 37(2):1977;546-550.
22. Miller F.R., Miller B.E., Heppner G.H. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Invasion Metastasis. 3(1):1983;22-31.
23. Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell. 23(1):1981;175-182.
24. Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem. Pharm. Bull. 36(3):1988;1095-1103.
25. Jeffery H., Davis S.S., O'Hagan D.T. The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 10(3):1993;362-368.
26. J. Sambrook, E.E. Fritsch, T. Maniatis, Digesting DNA with restriction enzymes, in: Molecular Cloning, 2nd ed. Cold Spring Harbor Laboratory Press, New York, 1989, pp. 5.28-25.31.
27. J. Sambrook, E.E. Fritsch, T. Maniatis, Gel electrophoresis of DNA, in: Molecular Cloning, 2nd ed. Cold Spring Harbor Laboratory Press, New York, 1989, pp. 6.2-6.19.
28. Singer V.L., Jones L.J., Yue S.T., Haugland R.P. Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. Anal. Biochem. 249(2):1997;228-238.
29. Kimura H., Ogura Y., Moritera T., Honda Y., Tabata Y., Ikada Y. In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release. Curr. Eye Res. 13(5):1994;353-360.
30. Wasan E.K., Reimer D.L., Bally M.B. Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. J. Pharm. Sci. 85(4):1996;427-433.
31. Weintraub H., Cheng P.F., Conrad K. Expression of transfected DNA depends on DNA topology. Cell. 46(1):1986;115-122.
32. Ying C., Gorski J. DNA topology regulates rat prolactin gene transcription. Mol. Cell. Endocrinol. 99(2):1994;183-192.
33. Johnson O.L., Jaworowicz W., Cleland J.L., Bailey L., Charnis M., Duenas E., Wu C., Shepard D., Magil S., Last T., Jones A.J., Putney S.D. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 14(6):1997;730-735.
34. Alonso M.J., Cohen S., Park T.G., Gupta R.K., Siber G.R., Langer R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 10(7):1993;945-953.
35. Masihi K.N., Lange W., Johnson A.G., Ribi E. Enhancement of chemiluminescence and phagocytic activities by nontoxic and toxic forms of lipid A. J. Biol. Resp. Mod. 5(5):1986;462-469.
36. Johnson A.G., Tomai M.A. A study of the cellular and molecular mediators of the adjuvant action of a nontoxic monophosphoryl lipid A. Adv. Exp. Med. Biol. 256:1990;567-579.
37. Salkowski C.A., Detore G.R., Vogel S.N. Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages. Infect. Immun. 65(8):1997;3239-3247.
38. Sasaki S., Tsuji T., Hamajima K., Fukushima J., Ishii N., Kaneko T., Xin K.Q., Mohri H., Aoki I., Okubo T., Nishioka K., Okuda K. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immun. 65(9):1997;3520-3528.
39. Gregoriadis G., Saffie R., Hart S.L. High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency. J. Drug Target. 3(6):1996;469-475.
40. Gregoriadis G., Saffie R., de Souza J.B. Liposome-mediated DNA vaccination. FEBS Lett. 402(2-3):1997;107-110.
41. Scheule R.K., St George J.A., Bagley R.G., Marshall J., Kaplan J.M., Akita G.Y., Wang K.X., Lee E.R., Harris D.J., Jiang C., Yew N.S., Smith A.E., Cheng S.H. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther. 8(6):1997;689-707.